Cannabis In the US

For more than 50 years, cann*bis was placed in the same federal category as hero*n.

Now that category has changed.

After decades of debate, the federal government has moved mar*juana from Schedule I to Schedule III.

That means cann*bis is no longer classified alongside dr*gs such as hero*n and L/S/D, which are defined as having a high potential for abuse and no accepted medical use under federal law.

The change does not make mar*juana federally legal.

Recreational cann*bis remains illegal under federal law, and interstate cann*bis sales are still prohibited.

But the decision could have major consequences for science.

For years, researchers argued that Schedule I restrictions made mar*juana unusually difficult to study. Scientists often needed special licenses, faced strict federal rules, and had limited access to cann*bis products that did not match what people were actually using.

Moving cann*bis to Schedule III could make it easier to run clinical trials, study specific formulations, and better understand how mar*juana affects pain, nausea, appetite, memory, mental health, and addiction risk.

The shift comes as cann*bis use in the United States has increased sharply and medical mar*juana has become legal in most states.

Researchers say the new classification does not prove cann*bis is harmless.

Instead, it may finally make it easier to answer some of the biggest questions about where mar*juana helps, where it harms, and who is most at risk.